You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

CMEC Meeting 19, 6-7 April 2000

Complementary Medicines Evaluation Committee

6 April 2000

Extracted ratified minutes

How to access a pdf document

CMEC Meeting 19 extracted ratified minutes (pdf,33kb)

Public recommendation summary

Item 3 Report of the Working Party on Substantiation of Claims

Recommendation 19.1

CMEC endorses the work in progress on the amended document Guidelines for levels and kinds of evidence to support claims for therapeutic goods.

Item 6.1 Papain

Recommendation 19.2

CMEC recommends to the TGA that papain is suitable for use as an active ingredient in listable therapeutic goods, without any substance-specific restrictions.

Item 6.2 Methionine

Recommendation 19.3

CMEC recommends to the TGA that L-methionine is suitable for use as an active ingredient in listable therapeutic goods, without any substance-specific restrictions.

Item 6.4 Chondroitin sulfate

Recommendation 19.4

CMEC recommends to the TGA that bovine- and shark-chondroitin sulfate are suitable for use as active ingredients in listable therapeutic goods, without any substance-specific restrictions.

Top of page